New data shows GSK-Vir drug works against all Omicron mutations

The data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all 37 identified mutations to date in the spike protein, GSK said in a statement.

from News-Economic Times https://ift.tt/3Ivzqtd